We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Ligand Pharmaceuticals Incorporated (PK) | USOTC:LGNZZ | OTCMarkets | Right |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.109 | 0.10 | 0.13 | 0.00 | 13:43:24 |
Delaware
|
001-33093
|
77-0160744
|
||||||
(State or other jurisdiction of
incorporation or organization)
|
(Commission File Number)
|
(I.R.S. Employer
Identification No.)
|
||||||
3911 Sorrento Valley Boulevard, Suite 110 San Diego, CA
|
92121
(Zip Code)
|
|||||||
(Address of principal executive offices)
|
Exhibit No.
|
Description
|
||||
Press release dated
November 8
, 2018.
|
Date:
N
ovember 8
, 2018
|
By:
/s/ Matthew Korenberg
Name: Matthew Korenberg
Title: Executive Vice President, Finance and Chief Financial Officer
|
Exhibit No.
|
Description
|
||||
Press release dated
November 8
, 2018.
|
1 Year Ligand Pharmaceuticals (PK) Chart |
1 Month Ligand Pharmaceuticals (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions